Bhagirath Pranav, Beunder Kyle, van Halm Vokko
Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
J Cardiovasc Electrophysiol. 2021 Jan;32(1):166-168. doi: 10.1111/jce.14823. Epub 2020 Dec 7.
An 81-year-old male with a history of systolic heart failure due to an underlying ischemic cardiomyopathy with a left ventricular ejection fraction of 13% and QRS duration of 130 ms had undergone an uncomplicated cardiac resynchronization therapy defibrillator implantation (Quadra Assura MP, St. Jude Medical, LV lead (SJM Quartet 1458Q-86), RA lead (Biotronik Safio S53) and RV shocklead (Biotronik Linox Smart S65 ProMRI) in 2015.
一名81岁男性,有潜在缺血性心肌病导致的收缩性心力衰竭病史,左心室射血分数为13%,QRS波时限为130毫秒,于2015年接受了一次无并发症的心脏再同步化治疗除颤器植入手术(采用圣犹达医疗公司的Quadra Assura MP,左心室导线(圣犹达四分体1458Q - 86),右心房导线(百多力Safio S53)和右心室除颤导线(百多力Linox Smart S65 ProMRI))。